Sutro Biopharma (STRO) Other Non-Current Liabilities (2017 - 2025)

Sutro Biopharma (STRO) has 9 years of Other Non-Current Liabilities data on file, last reported at $1.7 million in Q4 2025.

• For the quarter ending Q4 2025, Other Non-Current Liabilities changed 0.0% year-over-year to $1.7 million; the trailing twelve-month figure through Dec 2025 stood at $1.7 million (changed 0.0% YoY), and the FY2025 full-year result was $1.7 million, changed 0.0% from the prior year.
• Other Non-Current Liabilities held at $1.7 million in Q4 2025, from $1.7 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $1.7 million in Q4 2023 to a low of $119000.0 in Q4 2022.
• A 5-year average of $1.1 million and a median of $1.7 million in 2023 frame the typical range for Other Non-Current Liabilities.
• Across the five-year window, Other Non-Current Liabilities sank 91.16% in 2022 and surged 1323.53% in 2023, its largest moves.
• Tracing STRO's Other Non-Current Liabilities over 5 years: stood at $146000.0 in 2021, then slipped by 18.49% to $119000.0 in 2022, then surged by 1323.53% to $1.7 million in 2023, then changed by 0.0% to $1.7 million in 2024, then changed by 0.0% to $1.7 million in 2025.
• Business Quant data shows STRO's Other Non-Current Liabilities at $1.7 million in Q4 2025, $1.7 million in Q3 2025, and $1.7 million in Q2 2025.